Canada Life’s Enovis ENOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-39,292
| Closed | -$3.11M | – | 2482 |
|
|
2021
Q4 | $3.11M | Buy |
39,292
+4,400
| +13% | +$368K | 0.01% | 963 |
|
|
2021
Q3 | $2.78M | Buy |
34,892
+8,562
| +33% | +$688K | 0.01% | 982 |
|
|
2021
Q2 | $2.08M | Buy |
26,330
+478
| +2% | +$36.6K | ﹤0.01% | 1129 |
|
|
2021
Q1 | $1.95M | Buy |
25,852
+798
| +3% | +$58.5K | ﹤0.01% | 1174 |
|
|
2020
Q4 | $1.65M | Sell |
25,054
-3,392
| -12% | -$198K | ﹤0.01% | 1252 |
|
|
2020
Q3 | $1.53M | Buy |
28,446
+3,289
| +13% | +$181K | ﹤0.01% | 1206 |
|
|
2020
Q2 | $1.21M | Sell |
25,157
-346
| -1% | -$15.3K | ﹤0.01% | 1337 |
|
|
2020
Q1 | $869K | Buy |
25,503
+2,013
| +9% | +$111K | ﹤0.01% | 1360 |
|
|
2019
Q4 | $1.46M | Buy |
+23,490
| New | +$1.33M | ﹤0.01% | 1315 |
|
|
2019
Q3 | – | Sell |
-31,547
| Closed | -$1.52M | – | 1462 |
|
|
2019
Q2 | $1.52M | Sell |
31,547
-1,634
| -5% | -$78.7K | ﹤0.01% | 1335 |
|
|
2019
Q1 | $1.69M | Buy |
33,181
+26,620
| +406% | +$1.17M | ﹤0.01% | 1146 |
|
|
2018
Q4 | $228K | Buy |
6,561
+1,241
| +23% | +$57.9K | ﹤0.01% | 1896 |
|
|
2018
Q3 | $331K | Hold |
5,320
| – | – | ﹤0.01% | 1844 |
|
|
2018
Q2 | $281K | Sell |
5,320
-1,340
| -20% | -$72.4K | ﹤0.01% | 1883 |
|
|
2018
Q1 | $366K | Hold |
6,660
| – | – | ﹤0.01% | 1806 |
|
|
2017
Q4 | $453K | Hold |
6,660
| – | – | ﹤0.01% | 1763 |
|
|
2017
Q3 | $480K | Buy |
6,660
+1,259
| +23% | +$87.6K | ﹤0.01% | 1729 |
|
|
2017
Q2 | $365K | Hold |
5,401
| – | – | ﹤0.01% | 1776 |
|
|
2017
Q1 | $364K | Hold |
5,401
| – | – | ﹤0.01% | 1780 |
|
|
2016
Q4 | $335K | Sell |
5,401
-1,336
| -20% | -$79K | ﹤0.01% | 1778 |
|
|
2016
Q3 | $364K | Hold |
6,737
| – | – | ﹤0.01% | 1745 |
|
|
2016
Q2 | $306K | Hold |
6,737
| – | – | ﹤0.01% | 1766 |
|
|
2016
Q1 | $331K | Sell |
6,737
-10,606
| -61% | -$451K | ﹤0.01% | 1048 |
|
|
2015
Q4 | $697K | Hold |
17,343
| – | – | ﹤0.01% | 861 |
|
|
2015
Q3 | $895K | Hold |
17,343
| – | – | ﹤0.01% | 827 |
|
|
2015
Q2 | $1.37M | Buy |
17,343
+514
| +3% | +$43.5K | ﹤0.01% | 872 |
|
|
2015
Q1 | $1.38M | Hold |
16,829
| – | – | ﹤0.01% | 863 |
|
|
2014
Q4 | $1.49M | Hold |
16,829
| – | – | ﹤0.01% | 837 |
|
|
2014
Q3 | $1.66M | Buy |
16,829
+14,050
| +506% | +$1.58M | 0.01% | 817 |
|
|
2014
Q2 | $355K | Buy |
2,779
+721
| +35% | +$90K | ﹤0.01% | 948 |
|
|
2014
Q1 | $251K | Hold |
2,058
| – | – | ﹤0.01% | 1027 |
|
|
2013
Q4 | $227K | Hold |
2,058
| – | – | ﹤0.01% | 1040 |
|
|
2013
Q3 | $199K | Buy |
+2,058
| New | +$190K | ﹤0.01% | 920 |
|
Other funds holding ENOV
CB
DCP
SV
SCA
CCMLC
Canada Life's ENOV Position: Q1 2022 in Review
Canada Life sold out of Enovis (ENOV) in Q1 2022, closing a stake of 39,292 shares — an estimated $3.11M sold.
Canada Life first reported a position in ENOV in Q3 2013 and held it in 33 quarters. The position peaked at $3.11M in Q4 2021. 298 funds tracked by Wall St. Rank hold ENOV as of Q1 2022.
- Canada Life reported no remaining Enovis position as of Q1 2022 after selling out during the quarter.
- Canada Life sold 39,292 Enovis shares in Q1 2022, an estimated $3.11M.
- Canada Life first reported a position in Enovis in Q3 2013 and held it in 33 quarters.
- Canada Life's Enovis position peaked at $3.11M in Q4 2021.
- 298 funds tracked by Wall St. Rank held Enovis as of Q1 2022.
Based on Canada Life's 13F filing for Q1 2022, filed 12 May 2022.